These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16646289)

  • 1. [Practical application of proliferation markers' (MIB-1, PCNA, AgNOR) expression analysis for differential diagnostics of nodular thyroid lesions].
    Lewy-Trenda I; Janczukowicz J; Wierzchniewska-Lawska A
    Wiad Lek; 2006; 59(1-2):32-7. PubMed ID: 16646289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
    Lewy-Trenda I; Bieńkiewicz M
    Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
    Wang SL; Li SH; Chen WT; Chai CY
    APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study in differential diagnosis of benign and malignant lesions of the thyroid gland].
    Kazantseva IA; Fedosenko AK; Gurevich LE
    Arkh Patol; 2001; 63(4):18-21. PubMed ID: 11534185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
    Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
    Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric studies on fine-needle aspirates from follicular proliferative lesions of the thyroid.
    Cavallari V; Maiorana A; La Rosa GL; Maiorana MC; Scimone S; Fano RA
    Pathologica; 1989; 81(1074):441-6. PubMed ID: 2626280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometry in the cytologic evaluation of thyroid follicular lesions.
    Nagashima T; Suzuki M; Oshida M; Hashimoto H; Yagata H; Shishikura T; Koda K; Nakajima N
    Cancer; 1998 Apr; 84(2):115-8. PubMed ID: 9570215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic contribution of HBME-1 and anti-cytokeratin-19 antibodies in thyroid pathology: a retrospective study of 163 cases].
    Ziadi S; Trimeche M; Zermani R; Elmay A; Baltagi-Ben Jilani S
    Tunis Med; 2005 May; 83(5):274-8. PubMed ID: 16044900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
    Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between follicular adenoma and follicular carcinoma of the thyroid by nuclear DNA determination.
    Sprenger E; Löwhagen T; Vogt-Schaden M
    Acta Cytol; 1977; 21(4):528-30. PubMed ID: 269603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoarchitectural and kinetic features in the histological evaluation of follicular thyroid neoplasms.
    Arif S; Patel J; Blanes A; Diaz-Cano SJ
    Histopathology; 2007 May; 50(6):750-63. PubMed ID: 17493239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lesions of the thyroid: intraoperative cytology.
    Costa MJ; Sidawy MK
    Mod Pathol; 1989 Sep; 2(5):521-5. PubMed ID: 2813348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases.
    Ciobanu D; Căruntu ID; Vulpoi C; Florea N; Giuşcă SE
    Rom J Morphol Embryol; 2006; 47(4):323-30. PubMed ID: 17392977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
    Xu YJ
    Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases].
    Yang QX; Shao CK; Feng ZY; Huang BQ; Han AJ; Xiong M; Zhao WL; Wu TT
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):678-81. PubMed ID: 15958307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.